Edition:
India

ContraVir Pharmaceuticals Inc (CTRV.OQ)

CTRV.OQ on NASDAQ Stock Exchange Capital Market

1.56USD
1:30am IST
Change (% chg)

$-0.03 (-1.89%)
Prev Close
$1.59
Open
$1.63
Day's High
$1.65
Day's Low
$1.47
Volume
48,064
Avg. Vol
22,688
52-wk High
$6.56
52-wk Low
$1.32

Latest Key Developments (Source: Significant Developments)

Contravir expands scientific advisory board for Hepatitis B
Monday, 18 Jul 2016 

Contravir Pharmaceuticals : Carol L. Brosgart appointed chair of SAB in support of Contravir's development of a potentially curative therapy for hbv .Contravir expands scientific advisory board to focus on seeking curative therapy for Hepatitis B.  Full Article

BRIEF-Contravir Pharma Files For Series C Convertible Preferred Stock

* CONTRAVIR PHARMACEUTICALS FILES FOR SERIES C CONVERTIBLE PREFERRED STOCK AND WARRANTS TO PURCHASE SHARES OF COMMON STOCK OF UP TO $20 MILLION - SEC FILING Source text: (https://bit.ly/2wUNyv5) Further company coverage: